Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Reperfusion Injury | 33 | 2016 | 476 | 3.160 |
Why?
|
Heart Arrest, Induced | 30 | 2012 | 355 | 2.920 |
Why?
|
Ischemic Preconditioning, Myocardial | 13 | 2007 | 67 | 1.480 |
Why?
|
Cardioplegic Solutions | 16 | 2012 | 118 | 1.400 |
Why?
|
Myocardial Ischemia | 24 | 2012 | 2148 | 1.240 |
Why?
|
Mitochondria, Heart | 11 | 2012 | 247 | 1.170 |
Why?
|
Diazoxide | 9 | 2007 | 57 | 0.890 |
Why?
|
Potassium Channels | 9 | 2006 | 563 | 0.850 |
Why?
|
Myocardium | 28 | 2016 | 4772 | 0.840 |
Why?
|
Adenosine | 10 | 2003 | 825 | 0.770 |
Why?
|
Cardiotonic Agents | 6 | 2016 | 535 | 0.720 |
Why?
|
Coronary Artery Bypass | 14 | 2010 | 2288 | 0.710 |
Why?
|
Rabbits | 30 | 2016 | 4894 | 0.640 |
Why?
|
Calcium | 16 | 2008 | 5755 | 0.620 |
Why?
|
Myocardial Contraction | 13 | 2016 | 1579 | 0.530 |
Why?
|
Vasodilator Agents | 7 | 2003 | 976 | 0.520 |
Why?
|
Heart | 12 | 2000 | 4464 | 0.510 |
Why?
|
Aging | 14 | 2006 | 8664 | 0.480 |
Why?
|
Myocardial Reperfusion | 9 | 2007 | 351 | 0.440 |
Why?
|
Myocardial Revascularization | 2 | 2008 | 841 | 0.440 |
Why?
|
Magnesium | 8 | 2007 | 813 | 0.420 |
Why?
|
Cytosol | 8 | 1997 | 901 | 0.410 |
Why?
|
Blood | 5 | 2006 | 598 | 0.390 |
Why?
|
Cardiac Surgical Procedures | 10 | 2010 | 3537 | 0.380 |
Why?
|
Education, Distance | 1 | 2014 | 251 | 0.360 |
Why?
|
HSP70 Heat-Shock Proteins | 4 | 1996 | 404 | 0.350 |
Why?
|
Oxygen Consumption | 5 | 2008 | 1868 | 0.350 |
Why?
|
Adenosine Triphosphate | 6 | 2008 | 2027 | 0.330 |
Why?
|
Myocytes, Cardiac | 2 | 2008 | 1629 | 0.320 |
Why?
|
Thoracic Surgery | 1 | 2014 | 719 | 0.290 |
Why?
|
Sheep | 12 | 2001 | 1437 | 0.280 |
Why?
|
Pinacidil | 3 | 2000 | 10 | 0.280 |
Why?
|
Isotonic Solutions | 1 | 2006 | 119 | 0.280 |
Why?
|
Cardiopulmonary Bypass | 5 | 2003 | 1066 | 0.270 |
Why?
|
Mitochondria | 5 | 2016 | 3514 | 0.240 |
Why?
|
Ventricular Function, Left | 12 | 2008 | 3666 | 0.240 |
Why?
|
Societies, Medical | 2 | 2014 | 3743 | 0.230 |
Why?
|
Receptors, Purinergic P1 | 2 | 2001 | 109 | 0.230 |
Why?
|
Animals | 67 | 2016 | 168768 | 0.220 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2008 | 1873 | 0.220 |
Why?
|
Hemodynamics | 13 | 2004 | 4196 | 0.220 |
Why?
|
Thoracic Surgical Procedures | 1 | 2007 | 342 | 0.220 |
Why?
|
Mitochondrial Proteins | 1 | 2009 | 994 | 0.220 |
Why?
|
Potassium | 7 | 2007 | 1336 | 0.210 |
Why?
|
Education, Medical | 1 | 2014 | 1722 | 0.200 |
Why?
|
Myocardial Infarction | 15 | 2016 | 11718 | 0.200 |
Why?
|
Apoptosis | 6 | 2013 | 9724 | 0.200 |
Why?
|
Reperfusion Injury | 1 | 2008 | 1026 | 0.190 |
Why?
|
In Situ Nick-End Labeling | 4 | 2008 | 644 | 0.190 |
Why?
|
Echinococcosis | 1 | 2000 | 30 | 0.190 |
Why?
|
DNA, Mitochondrial | 2 | 2003 | 817 | 0.180 |
Why?
|
Ischemia | 1 | 2009 | 1907 | 0.180 |
Why?
|
Myocardial Stunning | 4 | 2006 | 68 | 0.180 |
Why?
|
RNA, Messenger | 8 | 2013 | 13035 | 0.170 |
Why?
|
Cost Control | 2 | 1998 | 624 | 0.160 |
Why?
|
Protein Kinase C | 2 | 2000 | 1227 | 0.160 |
Why?
|
Caspases | 3 | 2008 | 928 | 0.150 |
Why?
|
Cell Nucleus | 3 | 1997 | 2969 | 0.150 |
Why?
|
Phosphodiesterase Inhibitors | 2 | 2000 | 215 | 0.150 |
Why?
|
Preventive Medicine | 1 | 1999 | 264 | 0.150 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 1996 | 40 | 0.150 |
Why?
|
Guanidines | 2 | 2001 | 193 | 0.150 |
Why?
|
Ribonucleotides | 1 | 1997 | 117 | 0.150 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 1997 | 175 | 0.140 |
Why?
|
Phosphocreatine | 1 | 1997 | 269 | 0.140 |
Why?
|
Cardiomyopathies | 2 | 1999 | 1912 | 0.140 |
Why?
|
Swine | 11 | 2007 | 5918 | 0.140 |
Why?
|
Graft Occlusion, Vascular | 1 | 1999 | 549 | 0.130 |
Why?
|
Sex Characteristics | 1 | 2006 | 2585 | 0.130 |
Why?
|
Proteomics | 4 | 2013 | 3638 | 0.130 |
Why?
|
Gene Deletion | 1 | 2003 | 2751 | 0.130 |
Why?
|
Mitochondria, Muscle | 1 | 2016 | 171 | 0.130 |
Why?
|
Aprotinin | 1 | 1995 | 88 | 0.130 |
Why?
|
Hyperthermia, Induced | 2 | 1996 | 403 | 0.130 |
Why?
|
Electron Transport Complex IV | 1 | 1995 | 189 | 0.130 |
Why?
|
Muscle Relaxation | 1 | 1995 | 142 | 0.130 |
Why?
|
Ventricular Pressure | 4 | 2012 | 199 | 0.130 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2013 | 691 | 0.130 |
Why?
|
Faith Healing | 2 | 2006 | 27 | 0.120 |
Why?
|
Heart Rate | 7 | 2008 | 4092 | 0.120 |
Why?
|
Coronary Vessels | 3 | 2016 | 3107 | 0.120 |
Why?
|
Creatine Kinase | 3 | 2013 | 694 | 0.120 |
Why?
|
Postoperative Complications | 8 | 2010 | 15297 | 0.120 |
Why?
|
Perfusion | 4 | 2006 | 1360 | 0.120 |
Why?
|
Coronary Circulation | 7 | 2002 | 1572 | 0.120 |
Why?
|
Calcium Channels | 1 | 1997 | 622 | 0.120 |
Why?
|
Sex Factors | 2 | 2007 | 10400 | 0.110 |
Why?
|
Necrosis | 4 | 2006 | 1643 | 0.110 |
Why?
|
Energy Metabolism | 3 | 2006 | 2897 | 0.110 |
Why?
|
Blood Pressure | 7 | 2008 | 8551 | 0.110 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 1997 | 871 | 0.110 |
Why?
|
Creatine Kinase, MB Form | 2 | 2016 | 214 | 0.110 |
Why?
|
Sarcolemma | 2 | 2003 | 66 | 0.110 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2012 | 110 | 0.110 |
Why?
|
Heparin | 1 | 1999 | 1637 | 0.100 |
Why?
|
Tachycardia, Ventricular | 1 | 2000 | 1273 | 0.100 |
Why?
|
Age Factors | 2 | 2007 | 18373 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 1999 | 1178 | 0.100 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 12073 | 0.090 |
Why?
|
Reimbursement Mechanisms | 1 | 1996 | 670 | 0.090 |
Why?
|
Male | 48 | 2013 | 350115 | 0.090 |
Why?
|
Collagen Type V | 1 | 2009 | 16 | 0.090 |
Why?
|
Collagen Type XI | 1 | 2009 | 20 | 0.090 |
Why?
|
Alpha-Amanitin | 1 | 2009 | 7 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 1999 | 1239 | 0.090 |
Why?
|
Pyridones | 1 | 1994 | 711 | 0.080 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2008 | 46 | 0.080 |
Why?
|
Potassium Chloride | 3 | 2000 | 237 | 0.080 |
Why?
|
Troponin C | 1 | 2008 | 25 | 0.080 |
Why?
|
Cycloheximide | 1 | 2009 | 347 | 0.080 |
Why?
|
Ventricular Fibrillation | 1 | 1991 | 538 | 0.080 |
Why?
|
Blotting, Western | 3 | 2009 | 5181 | 0.080 |
Why?
|
Postoperative Period | 3 | 2006 | 1842 | 0.080 |
Why?
|
DNA Damage | 2 | 1995 | 2432 | 0.080 |
Why?
|
Temperature | 4 | 1996 | 2204 | 0.080 |
Why?
|
Magnesium Sulfate | 2 | 2000 | 68 | 0.080 |
Why?
|
Metabolism | 1 | 2009 | 196 | 0.080 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2012 | 857 | 0.070 |
Why?
|
Health Care Reform | 1 | 1996 | 1261 | 0.070 |
Why?
|
Hot Temperature | 1 | 1993 | 1356 | 0.070 |
Why?
|
Female | 35 | 2016 | 380193 | 0.070 |
Why?
|
Warm Ischemia | 1 | 2006 | 53 | 0.070 |
Why?
|
Adherens Junctions | 1 | 2006 | 90 | 0.070 |
Why?
|
Anticoagulants | 2 | 1999 | 4600 | 0.070 |
Why?
|
Diastole | 4 | 2000 | 791 | 0.070 |
Why?
|
Microarray Analysis | 1 | 2009 | 767 | 0.070 |
Why?
|
Free Radicals | 1 | 2006 | 237 | 0.070 |
Why?
|
Blotting, Northern | 3 | 1997 | 1581 | 0.070 |
Why?
|
Fetal Blood | 1 | 2012 | 1318 | 0.070 |
Why?
|
Potassium Channel Blockers | 2 | 2003 | 171 | 0.070 |
Why?
|
History, 20th Century | 1 | 2014 | 2740 | 0.070 |
Why?
|
Length of Stay | 4 | 1998 | 6311 | 0.070 |
Why?
|
DNA, Complementary | 1 | 2009 | 2050 | 0.070 |
Why?
|
Disease Models, Animal | 9 | 2016 | 18034 | 0.070 |
Why?
|
Ion Transport | 1 | 2006 | 320 | 0.060 |
Why?
|
Base Sequence | 2 | 2009 | 12797 | 0.060 |
Why?
|
Time Factors | 9 | 2016 | 40075 | 0.060 |
Why?
|
Gap Junctions | 1 | 2006 | 233 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4751 | 0.060 |
Why?
|
Cardiology | 1 | 1996 | 1668 | 0.060 |
Why?
|
Technology | 1 | 2007 | 304 | 0.060 |
Why?
|
Drug Combinations | 2 | 2007 | 1958 | 0.060 |
Why?
|
Stents | 2 | 2006 | 3282 | 0.060 |
Why?
|
Muscle Contraction | 1 | 2009 | 1235 | 0.060 |
Why?
|
Cytochromes b | 1 | 2003 | 36 | 0.060 |
Why?
|
Professional Role | 1 | 2007 | 306 | 0.060 |
Why?
|
Stroke Volume | 4 | 2003 | 5006 | 0.060 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2003 | 52 | 0.060 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2004 | 190 | 0.060 |
Why?
|
Molecular Sequence Data | 2 | 2009 | 18111 | 0.060 |
Why?
|
Humans | 35 | 2016 | 744366 | 0.060 |
Why?
|
STAT3 Transcription Factor | 1 | 2007 | 874 | 0.060 |
Why?
|
Peroxynitrous Acid | 1 | 2002 | 41 | 0.060 |
Why?
|
Microscopy, Electron | 2 | 2004 | 2646 | 0.050 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 1970 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2006 | 850 | 0.050 |
Why?
|
Phenanthrenes | 1 | 2002 | 63 | 0.050 |
Why?
|
Aged | 15 | 2013 | 163288 | 0.050 |
Why?
|
bcl-2-Associated X Protein | 1 | 2002 | 295 | 0.050 |
Why?
|
Commerce | 1 | 2007 | 592 | 0.050 |
Why?
|
Purinergic P1 Receptor Agonists | 1 | 2001 | 38 | 0.050 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 2001 | 45 | 0.050 |
Why?
|
Dihydropyridines | 1 | 2001 | 67 | 0.050 |
Why?
|
Fatty Acids | 1 | 2009 | 1809 | 0.050 |
Why?
|
Cerebral Infarction | 1 | 2006 | 1011 | 0.050 |
Why?
|
Amrinone | 1 | 2000 | 14 | 0.050 |
Why?
|
Uncertainty | 1 | 2006 | 735 | 0.050 |
Why?
|
Ischemic Preconditioning | 1 | 2001 | 92 | 0.050 |
Why?
|
Xanthines | 1 | 2001 | 121 | 0.050 |
Why?
|
Thiourea | 1 | 2000 | 63 | 0.050 |
Why?
|
Models, Cardiovascular | 1 | 2006 | 996 | 0.050 |
Why?
|
Heart Conduction System | 1 | 2006 | 1047 | 0.050 |
Why?
|
Heart Diseases | 1 | 1994 | 2789 | 0.050 |
Why?
|
Travel | 1 | 2007 | 788 | 0.050 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2002 | 440 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2006 | 1375 | 0.050 |
Why?
|
Genetic Testing | 1 | 2013 | 3444 | 0.050 |
Why?
|
Caspase 3 | 1 | 2002 | 758 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 3 | 1996 | 8300 | 0.040 |
Why?
|
Transplantation, Autologous | 2 | 2016 | 2124 | 0.040 |
Why?
|
Preoperative Care | 1 | 2008 | 2251 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1782 | 0.040 |
Why?
|
Hospitalization | 1 | 1998 | 10259 | 0.040 |
Why?
|
Medicare | 1 | 1996 | 6566 | 0.040 |
Why?
|
Oligopeptides | 1 | 2004 | 1189 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2009 | 11366 | 0.040 |
Why?
|
Infusions, Intra-Arterial | 1 | 1998 | 234 | 0.040 |
Why?
|
Systole | 3 | 2000 | 958 | 0.040 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 1997 | 84 | 0.040 |
Why?
|
Lipid Peroxidation | 2 | 1995 | 270 | 0.040 |
Why?
|
Sequence Analysis, DNA | 1 | 2009 | 4805 | 0.040 |
Why?
|
Age Distribution | 1 | 2003 | 2902 | 0.040 |
Why?
|
Delirium | 1 | 2008 | 1610 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 6994 | 0.040 |
Why?
|
Organ Size | 2 | 2000 | 2251 | 0.040 |
Why?
|
Rats | 5 | 1996 | 24252 | 0.040 |
Why?
|
Buffers | 1 | 1996 | 147 | 0.030 |
Why?
|
Heart Ventricles | 2 | 2012 | 3817 | 0.030 |
Why?
|
Action Potentials | 2 | 2000 | 1806 | 0.030 |
Why?
|
Recovery of Function | 2 | 2004 | 2926 | 0.030 |
Why?
|
Ruthenium Red | 1 | 1995 | 19 | 0.030 |
Why?
|
Injections | 1 | 1999 | 840 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1434 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2010 | 4043 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1996 | 821 | 0.030 |
Why?
|
Cold Temperature | 1 | 1999 | 772 | 0.030 |
Why?
|
Health Care Costs | 2 | 2007 | 3208 | 0.030 |
Why?
|
Sus scrofa | 1 | 2016 | 437 | 0.030 |
Why?
|
Proteins | 2 | 2009 | 6100 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2006 | 3084 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2008 | 57776 | 0.030 |
Why?
|
Anaerobiosis | 1 | 1994 | 140 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1997 | 2556 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2219 | 0.030 |
Why?
|
Magnesium Chloride | 1 | 1993 | 32 | 0.030 |
Why?
|
Fura-2 | 1 | 1994 | 109 | 0.030 |
Why?
|
Stimulation, Chemical | 1 | 1994 | 326 | 0.030 |
Why?
|
Acute-Phase Reaction | 1 | 1994 | 91 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6171 | 0.030 |
Why?
|
Deoxyglucose | 1 | 1994 | 337 | 0.030 |
Why?
|
Milrinone | 1 | 1994 | 84 | 0.030 |
Why?
|
Lactates | 1 | 1994 | 432 | 0.030 |
Why?
|
Catheterization, Central Venous | 1 | 1998 | 514 | 0.030 |
Why?
|
Phosphates | 1 | 1997 | 785 | 0.030 |
Why?
|
Liver Diseases, Alcoholic | 1 | 1995 | 161 | 0.030 |
Why?
|
Calcium-Transporting ATPases | 1 | 1993 | 123 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7294 | 0.030 |
Why?
|
Voltage-Sensitive Dye Imaging | 1 | 2013 | 31 | 0.030 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1992 | 60 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2006 | 3531 | 0.030 |
Why?
|
Calcium Channel Blockers | 1 | 1996 | 692 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9445 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 1998 | 818 | 0.030 |
Why?
|
Troponin I | 1 | 2016 | 619 | 0.030 |
Why?
|
Pentose Phosphate Pathway | 1 | 2012 | 124 | 0.030 |
Why?
|
Echocardiography | 2 | 2016 | 5099 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 1993 | 379 | 0.030 |
Why?
|
Gene Expression | 2 | 1995 | 7798 | 0.030 |
Why?
|
Ligation | 1 | 2012 | 453 | 0.030 |
Why?
|
Ethanol | 2 | 1995 | 1342 | 0.030 |
Why?
|
United States | 3 | 2014 | 69872 | 0.030 |
Why?
|
Swine, Miniature | 1 | 1994 | 961 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 1993 | 383 | 0.030 |
Why?
|
Fees and Charges | 1 | 1992 | 195 | 0.020 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 1992 | 219 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 1995 | 662 | 0.020 |
Why?
|
Microspheres | 1 | 1994 | 777 | 0.020 |
Why?
|
Middle Aged | 10 | 2013 | 213390 | 0.020 |
Why?
|
Linear Models | 3 | 2000 | 5953 | 0.020 |
Why?
|
Extracellular Space | 1 | 2013 | 595 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3799 | 0.020 |
Why?
|
Isoenzymes | 1 | 1995 | 1728 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2012 | 411 | 0.020 |
Why?
|
RNA | 1 | 2000 | 2749 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 940 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 1997 | 1312 | 0.020 |
Why?
|
Nitroprusside | 1 | 1990 | 275 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1993 | 1681 | 0.020 |
Why?
|
Oxidative Phosphorylation | 1 | 2012 | 481 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 1994 | 1525 | 0.020 |
Why?
|
Dietary Fats | 2 | 1995 | 2016 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2002 | 4554 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 1999 | 2419 | 0.020 |
Why?
|
Phenylephrine | 1 | 1990 | 301 | 0.020 |
Why?
|
Hypothermia, Induced | 1 | 1995 | 752 | 0.020 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2010 | 170 | 0.020 |
Why?
|
Body Weight | 1 | 2000 | 4671 | 0.020 |
Why?
|
Oximetry | 1 | 1993 | 471 | 0.020 |
Why?
|
Lactic Acid | 1 | 1994 | 1132 | 0.020 |
Why?
|
Adult | 8 | 2003 | 214052 | 0.020 |
Why?
|
Electrocardiography | 2 | 2000 | 6442 | 0.020 |
Why?
|
Troponin | 1 | 2013 | 524 | 0.020 |
Why?
|
Statistics as Topic | 1 | 1995 | 2373 | 0.020 |
Why?
|
Reoperation | 1 | 1998 | 4201 | 0.020 |
Why?
|
Propranolol | 1 | 1990 | 502 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2007 | 5321 | 0.020 |
Why?
|
Elasticity | 1 | 1990 | 657 | 0.020 |
Why?
|
Reference Values | 1 | 1996 | 4982 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2006 | 63107 | 0.020 |
Why?
|
Glycolysis | 1 | 2012 | 829 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2012 | 721 | 0.020 |
Why?
|
Electrophoresis | 1 | 2007 | 240 | 0.020 |
Why?
|
Cardiac Pacing, Artificial | 1 | 1991 | 845 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2012 | 2726 | 0.020 |
Why?
|
Genetic Markers | 1 | 2013 | 2634 | 0.020 |
Why?
|
Ultrasonography | 1 | 2000 | 5984 | 0.020 |
Why?
|
Creatinine | 1 | 1992 | 1919 | 0.020 |
Why?
|
Antioxidants | 1 | 1995 | 1659 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1997 | 3759 | 0.020 |
Why?
|
Internship and Residency | 1 | 2007 | 5791 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2013 | 2715 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2000 | 7721 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 3130 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2012 | 1084 | 0.020 |
Why?
|
Reference Standards | 1 | 2010 | 1025 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 1994 | 2076 | 0.020 |
Why?
|
Patient Readmission | 1 | 2000 | 3116 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2006 | 6486 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 1995 | 2269 | 0.020 |
Why?
|
Prognosis | 2 | 2003 | 29060 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15078 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1707 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2002 | 7882 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3921 | 0.010 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2006 | 493 | 0.010 |
Why?
|
Dopamine | 1 | 1990 | 1591 | 0.010 |
Why?
|
Tyrosine | 1 | 2007 | 1462 | 0.010 |
Why?
|
Random Allocation | 1 | 2007 | 2428 | 0.010 |
Why?
|
Aorta | 1 | 1990 | 2062 | 0.010 |
Why?
|
Cohort Studies | 2 | 2008 | 40559 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7323 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2009 | 1741 | 0.010 |
Why?
|
Rats, Wistar | 2 | 1995 | 1892 | 0.010 |
Why?
|
Hydroxy Acids | 1 | 2000 | 18 | 0.010 |
Why?
|
Safety | 1 | 2006 | 1186 | 0.010 |
Why?
|
Decanoic Acids | 1 | 2000 | 67 | 0.010 |
Why?
|
Glyburide | 1 | 2000 | 113 | 0.010 |
Why?
|
Liver | 2 | 1995 | 7475 | 0.010 |
Why?
|
Heart Function Tests | 1 | 2000 | 328 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1992 | 5388 | 0.010 |
Why?
|
Boston | 1 | 1992 | 9312 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2010 | 2265 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14723 | 0.010 |
Why?
|
Sulfones | 1 | 2001 | 436 | 0.010 |
Why?
|
Central Venous Pressure | 1 | 1998 | 78 | 0.010 |
Why?
|
Binding Sites | 1 | 2007 | 6111 | 0.010 |
Why?
|
Mediastinitis | 1 | 1998 | 48 | 0.010 |
Why?
|
Catheterization, Swan-Ganz | 1 | 1998 | 86 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 1992 | 12356 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20130 | 0.010 |
Why?
|
Risk Factors | 3 | 2008 | 72296 | 0.010 |
Why?
|
Prospective Studies | 3 | 2008 | 53290 | 0.010 |
Why?
|
Hospital Charges | 1 | 1998 | 362 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2000 | 789 | 0.010 |
Why?
|
Phosphorylation | 1 | 2007 | 8436 | 0.010 |
Why?
|
Corn Oil | 1 | 1995 | 29 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16367 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21748 | 0.010 |
Why?
|
Microsomes, Liver | 1 | 1995 | 173 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2506 | 0.010 |
Why?
|
Postoperative Hemorrhage | 1 | 1998 | 412 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1994 | 25628 | 0.010 |
Why?
|
DNA Replication | 1 | 2000 | 1399 | 0.010 |
Why?
|
Optical Fibers | 1 | 1994 | 138 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7282 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13286 | 0.010 |
Why?
|
Fluoresceins | 1 | 1992 | 235 | 0.010 |
Why?
|
Fiber Optic Technology | 1 | 1994 | 290 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2001 | 6366 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 1998 | 804 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17446 | 0.010 |
Why?
|
Fish Oils | 1 | 1995 | 470 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 1994 | 688 | 0.010 |
Why?
|
Sulfonamides | 1 | 2000 | 1940 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1998 | 1504 | 0.010 |
Why?
|
Logistic Models | 1 | 2006 | 13409 | 0.010 |
Why?
|
Obesity | 1 | 1992 | 12746 | 0.010 |
Why?
|
Coloring Agents | 1 | 1992 | 566 | 0.010 |
Why?
|
Patient Selection | 1 | 2002 | 4216 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 35425 | 0.010 |
Why?
|
Alkanes | 1 | 1969 | 45 | 0.010 |
Why?
|
Biological Transport | 1 | 1993 | 2120 | 0.010 |
Why?
|
Acrylates | 1 | 1969 | 89 | 0.010 |
Why?
|
Cyanides | 1 | 1969 | 83 | 0.010 |
Why?
|
Heart Failure | 1 | 1992 | 10895 | 0.010 |
Why?
|
Retrospective Studies | 2 | 1998 | 77460 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2000 | 2873 | 0.000 |
Why?
|
Tissue Adhesives | 1 | 1969 | 179 | 0.000 |
Why?
|
Military Medicine | 1 | 1969 | 176 | 0.000 |
Why?
|
Hemostatics | 1 | 1969 | 229 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 1999 | 12244 | 0.000 |
Why?
|
Intensive Care Units | 1 | 1998 | 3680 | 0.000 |
Why?
|
Hospital Mortality | 1 | 1998 | 5316 | 0.000 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1998 | 3338 | 0.000 |
Why?
|
Glucose | 1 | 1995 | 4398 | 0.000 |
Why?
|
Software | 1 | 1994 | 4441 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2000 | 39052 | 0.000 |
Why?
|
Wounds and Injuries | 1 | 1969 | 2400 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1998 | 11726 | 0.000 |
Why?
|
Vietnam | 1 | 1969 | 408 | 0.000 |
Why?
|
Peritoneum | 1 | 1969 | 228 | 0.000 |
Why?
|
Kidney | 1 | 1969 | 7184 | 0.000 |
Why?
|
Adolescent | 1 | 1969 | 85779 | 0.000 |
Why?
|